PPARA and type 2 diabetes mellitus: Transgenic mice with a cardiac-specific overexpression of PPARα developed cardiac hypertrophy and ventricular dysfunction, which suggests that the above-described metabolic perturbations are maladaptive in obesity/T2D [48].